Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a r...
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)
About this item
Full title
Author / Creator
Rades, Dirk , Bartscht, Tobias , Hunold, Peter , Schmidberger, Heinz , König, Laila , Debus, Jürgen , Belka, Claus , Homann, Nils , Spillner, Patrick , Petersen, Cordula , Kuhnt, Thomas , Fietkau, Rainer , Ridwelski, Karsten , Karcher-Kilian, Kerstin , Kranich, Anne , Männikkö, Sofia , Schild, Steven E. , Maderer, Annett and Moehler, Markus
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
To investigate the efficacy and toxicity of cetuximab when added to radiochemotherapy for unresectable esophageal cancer.
Methods
This randomized phase 2 trial (clinicaltrials.gov, identifier NCT01787006) compared radiochemotherapy plus cetuximab (arm A) to radiochemotherapy (arm B) for unresectable esophageal cancer. Primary objec...
Alternative Titles
Full title
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)
Authors, Artists and Contributors
Author / Creator
Bartscht, Tobias
Hunold, Peter
Schmidberger, Heinz
König, Laila
Debus, Jürgen
Belka, Claus
Homann, Nils
Spillner, Patrick
Petersen, Cordula
Kuhnt, Thomas
Fietkau, Rainer
Ridwelski, Karsten
Karcher-Kilian, Kerstin
Kranich, Anne
Männikkö, Sofia
Schild, Steven E.
Maderer, Annett
Moehler, Markus
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7449950
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7449950
Other Identifiers
ISSN
0179-7158
E-ISSN
1439-099X
DOI
10.1007/s00066-020-01646-4
